Adaptimmune Therapeutics (ADAP) Insider Trading & Ownership → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free ADAP Stock Alerts $1.08 +0.02 (+1.42%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Adaptimmune Therapeutics (NASDAQ:ADAP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.44%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$80,940.12 Get ADAP Insider Trade Alerts Want to know when executives and insiders are buying or selling Adaptimmune Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ADAP Insider Buying and Selling by Quarter Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Adaptimmune Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/16/2024Adrian RawcliffeCEOSell9,304$0.79$7,350.16 1/16/2024Elliot NorryInsiderSell2,287$0.79$1,806.73 1/16/2024William C Bertrand JrCOOSell4,681$0.79$3,697.99 1/12/2024William C Bertrand JrCOOSell5,220$0.85$4,437.00 1/11/2024Adrian RawcliffeCEOSell11,945$0.84$10,033.80 1/11/2024Elliot NorryInsiderSell4,009$0.84$3,367.56 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/1/2023Adrian RawcliffeCEOSell2,403$0.78$1,874.34 8/1/2023John LungerInsiderSell3,096$0.91$2,817.36 7/10/2023Garry E MenzelDirectorSell47,702$0.91$43,408.82 6/27/2023Adrian RawcliffeCEOSell2,333$0.92$2,146.36 (Data available from 1/1/2013 forward) ADAP Insider Trading Activity - Frequently Asked Questions Who is on Adaptimmune Therapeutics's Insider Roster? The list of insiders at Adaptimmune Therapeutics includes Adrian Rawcliffe, Cintia Piccina, Elliot Norry, Garry E Menzel, Gavin Wood, John Lunger, and William C Bertrand Jr. Learn more on insiders at ADAP. What percentage of Adaptimmune Therapeutics stock is owned by insiders? 12.44% of Adaptimmune Therapeutics stock is owned by insiders. Learn more on ADAP's insider holdings. Which Adaptimmune Therapeutics insiders have been buying company stock? The following insider purchased ADAP shares in the last 24 months: Gavin Wood ($11,310.00). How much insider buying is happening at Adaptimmune Therapeutics? Insiders have purchased a total of 39,000 ADAP shares in the last 24 months for a total of $11,310.00 bought. Which Adaptimmune Therapeutics insiders have been selling company stock? The following insiders have sold ADAP shares in the last 24 months: Adrian Rawcliffe ($89,940.76), Cintia Piccina ($22,234.30), Elliot Norry ($5,174.29), Garry E Menzel ($43,408.82), John Lunger ($28,254.56), and William C Bertrand Jr ($22,695.78). How much insider selling is happening at Adaptimmune Therapeutics? Insiders have sold a total of 166,757 Adaptimmune Therapeutics shares in the last 24 months for a total of $211,708.51 sold. More Insider Trading Tools from MarketBeat Related Companies: Scholar Rock Insider Transactions Tarsus Pharmaceuticals Insider Transactions Vir Biotechnology Insider Transactions 4D Molecular Therapeutics Insider Transactions BioCryst Pharmaceuticals Insider Transactions Kyverna Therapeutics Insider Transactions REGENXBIO Insider Transactions ADMA Biologics Insider Transactions Relay Therapeutics Insider Transactions CARGO Therapeutics Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:ADAP) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptimmune Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
